MedTrace Logo

Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB)

NCT00114088 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 242

Last updated 2005-06-24

No results posted yet for this study

Summary

STOP-DUB is a multicenter randomized clinical trial that is assessing the efficacy and effectiveness of hysterectomy versus endometrial ablation (EA) for dysfunctional uterine bleeding (DUB) in women for whom medical management has not provided relief.

Conditions

  • Menorrhagia
  • Uterine Bleeding

Interventions

PROCEDURE

hysterectomy

PROCEDURE

endometrial ablation

Sponsors & Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

    lead FED

Principal Investigators

  • Kay Dickersin, PhD · Brown University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-11-30
Completion
2004-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00114088 on ClinicalTrials.gov